Novartis Meets Offer Conditions To Buy MorphoSys In EUR 68/shr Cash Deal

Novartis Pharma AG, affiliated to Swiss drug major Novartis AG (NVS), announced Thursday that it has met all tender offer conditions to acquire MorphoSys AG (MOR) for EUR 68 per share in cash.